Predictors of chemotherapy dose reduction at first cycle in patients age 65years and older with solid tumors-Reference-Cited by-同舟云学术

Predictors of chemotherapy dose reduction at first cycle in patients age 65years and older with solid tumors

Published:2015-03 Issue:2 Volume:6 Page:133-140
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Gajra Ajeet,Klepin Heidi D.,Feng Tao,Tew William P.,Mohile Supriya G.,Owusu Cynthia,Gross Cary P.,Lichtman Stuart M.,Wildes Tanya M.,Chapman Andrew E.,Dotan Efrat,Katheria Vani,Zavala Laura,Akiba Chie,Hurria Arti

Funder

National Institutes of Health

NCI

NIH

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference30 articles.

1. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial;Langer;J Natl Cancer Inst,2002

2. Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: The Cancer and Leukemia Group B Experience;Muss;J Clin Oncol,2007

3. Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer;Hurria;Drugs Aging,2005

4. Greater risks of chemotherapy toxicity in elderly patients with cancer;Repetto;J Support Oncol,2003

5. Hematology in older persons;Shayne,2006

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy Primary Dose Reduction in Older Cancer Patients: A Retrospective Cohort;Cancer Investigation;2024-05-24

2. Primary Treatment Modification and Treatment Tolerability Among Older Chemotherapy Recipients With Advanced Cancer;JAMA Network Open;2024-02-15

3. Update on the management of older patients with pancreatic adenocarcinoma: a perspective from medical oncology;Clinical and Translational Oncology;2024-02-08

4. Patient-Derived Ex Vivo Cultures and Endpoint Assays with Surrogate Biomarkers in Functional Testing for Prediction of Therapeutic Response;Cancers;2023-08-15

5. PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma;Cancers;2023-08-10